【结 构 式】 |
【分子编号】50311 【品名】 【CA登记号】 |
【 分 子 式 】C19H21NO5 【 分 子 量 】343.37948 【元素组成】C 66.46% H 6.16% N 4.08% O 23.3% |
合成路线1
该中间体在本合成路线中的序号:(VI)The oxidative cyclization of the formamide derivative (I) with iodosobenzene bis(trifluoroacetate) (PIFA) gives the tricyclic semiquinone (II), which is debenzylated by means of TFA and Me2S and cyclized with Ms-OH to yield the tetracyclic ketone (III). Elimination of the extra OH group of (III) by means of Tf2O, Pd(OAc)2 and TEA affords the intermediate (IV), which is reduced by means of L-Selectride and LiAlH4 to provide racemic galanthamine (V). Finally, this compound is submitted to optical resolution to furnish the target (-)-galanthamine. Alternatively, the protection of the ketonic group of (IV) with ethyleneglycol and PPTS gives the spiroketal (VI), which is selectively reduced with LiAlH4 and hydrolyzed with HCl to yield racemic narwedine (VII). Finally, the reduction of (VII) with L-Selectride affords the already described racemic galanthamine.
【1】 Node, M.; et al.; An efficient synthesis of (±)-narwedine and (±)-galanthamine by an improved phenolic oxidative coupling. Angew Chem. Int Ed Engl 2001, 40, 16, 3060. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50307 | 3,5-bis(benzyloxy)-4-methoxybenzyl(4-hydroxyphenethyl)formamide | C31H31NO5 | 详情 | 详情 | |
(II) | 50308 | C31H29NO5 | 详情 | 详情 | ||
(III) | 50309 | (4aS,8aS)-2-hydroxy-3-methoxy-6-oxo-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepine-11(12H)-carbaldehyde | C17H17NO5 | 详情 | 详情 | |
(IV) | 50310 | (4aS,8aS)-3-methoxy-6-oxo-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepine-11(12H)-carbaldehyde | C17H17NO4 | 详情 | 详情 | |
(V) | 41226 | (4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol | 357-70-0 | C17H21NO3 | 详情 | 详情 |
(VI) | 50311 | C19H21NO5 | 详情 | 详情 | ||
(VII) | 36691 | (4aS,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-one | C17H19NO3 | 详情 | 详情 |